作者: 自制 時(shí)間: 2025-3-21 20:50 作者: blithe 時(shí)間: 2025-3-22 02:19 作者: BRIDE 時(shí)間: 2025-3-22 06:16 作者: forecast 時(shí)間: 2025-3-22 12:05
Submitted on: 21 October 2018.
Revised on: 09 February 2019.
Accepted on: 28 February 2019.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: Diaphragm 時(shí)間: 2025-3-22 15:11
Submitted on: 29 September 2020.
Revised on: 30 December 2020.
Accepted on: 05 February 2021.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: osteopath 時(shí)間: 2025-3-22 17:14
Submitted on: 26 July 2019.
Revised on: 07 November 2019.
Accepted on: 28 November 2019.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: jealousy 時(shí)間: 2025-3-22 23:36
Submitted on: 10 December 2002.
Revised on: 18 March 2003.
Accepted on: 12 May 2003.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: 昏迷狀態(tài) 時(shí)間: 2025-3-23 05:28 作者: 分貝 時(shí)間: 2025-3-23 08:11 作者: insincerity 時(shí)間: 2025-3-23 11:40
Submitted on: 24 August 2019.
Revised on: 27 October 2019.
Accepted on: 25 December 2019.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: mucous-membrane 時(shí)間: 2025-3-23 16:20 作者: 圓錐體 時(shí)間: 2025-3-23 21:57
Submitted on: 04 May 2023.
Revised on: 16 June 2023.
Accepted on: 18 July 2023.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: 使成整體 時(shí)間: 2025-3-24 00:08
Submitted on: 11 June 2009.
Revised on: 26 July 2009.
Accepted on: 16 August 2009.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: glacial 時(shí)間: 2025-3-24 03:30
Submitted on: 06 April 2019.
Revised on: 11 May 2019.
Accepted on: 03 June 2019.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: 完整 時(shí)間: 2025-3-24 07:19 作者: 廢除 時(shí)間: 2025-3-24 12:28 作者: 俗艷 時(shí)間: 2025-3-24 18:34 作者: 精致 時(shí)間: 2025-3-24 22:53
Submitted on: 14 September 2003.
Revised on: 19 November 2003.
Accepted on: 09 January 2004.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: Pseudoephedrine 時(shí)間: 2025-3-25 02:55
Submitted on: 19 December 2012.
Revised on: 16 January 2013.
Accepted on: 14 March 2013.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: 吸引力 時(shí)間: 2025-3-25 06:15 作者: LVAD360 時(shí)間: 2025-3-25 09:25 作者: 兩棲動(dòng)物 時(shí)間: 2025-3-25 12:20
Submitted on: 30 July 1999.
Revised on: 25 October 1999.
Accepted on: 24 November 1999.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: Genteel 時(shí)間: 2025-3-25 19:23 作者: 把…比做 時(shí)間: 2025-3-25 22:26
Submitted on: 18 November 2021.
Revised on: 07 March 2022.
Accepted on: 26 April 2022.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: 破裂 時(shí)間: 2025-3-26 00:33 作者: Limpid 時(shí)間: 2025-3-26 06:25
Submitted on: 11 January 2014.
Revised on: 16 April 2014.
Accepted on: 05 May 2014.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: languid 時(shí)間: 2025-3-26 09:57
Submitted on: 18 June 2008.
Revised on: 05 October 2008.
Accepted on: 25 October 2008.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: 不易燃 時(shí)間: 2025-3-26 14:16
Submitted on: 10 September 2009.
Revised on: 23 October 2009.
Accepted on: 10 November 2009.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: entrance 時(shí)間: 2025-3-26 19:26
Submitted on: 07 February 2017.
Revised on: 27 March 2017.
Accepted on: 11 May 2017.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: 外向者 時(shí)間: 2025-3-27 00:31 作者: 豐滿有漂亮 時(shí)間: 2025-3-27 02:47
Submitted on: 02 March 2002.
Revised on: 05 June 2002.
Accepted on: 14 July 2002.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: Rebate 時(shí)間: 2025-3-27 08:31
Submitted on: 13 November 2015.
Revised on: 04 January 2016.
Accepted on: 17 February 2016.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: blithe 時(shí)間: 2025-3-27 09:44 作者: invulnerable 時(shí)間: 2025-3-27 15:19
Submitted on: 11 May 2011.
Revised on: 01 July 2011.
Accepted on: 21 July 2011.
___________________IN VIVO---INT INST ANTICANCER RESEARCH作者: Mosaic 時(shí)間: 2025-3-27 20:24
Submitted on: 02 February 2021.
Revised on: 02 May 2021.
Accepted on: 28 June 2021.
___________________IN VIVO---INT INST ANTICANCER RESEARCH
